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1 http://royalsociety.org/uploadedFiles/Royal_So
mer_Science/2007/Exh19_Biobricks.pdf
2 https://www.atg-biosynthetics.com/index.php?pagThis review describes a European-funded project in the area of Synthetic Biology. The project seeks
to demonstrate the application of engineering techniques andmethodologies to the design and con-
struction of a biosensor for detecting drug–target interactions at the single-molecule level. Produc-
tion of the proteins required for the system followed the principle of previously described
‘‘bioparts’’ concepts (a system where a database of biological parts – promoters, genes, terminators,
linking tags and cleavage sequences – is used to construct novel gene assemblies) and cassette-type
assembly of gene expression systems (the concept of linking different ‘‘bioparts’’ to produce func-
tional ‘‘cassettes’’), but problems were quickly identiﬁed with these approaches. DNA substrates
for the device were also constructed using a cassette-system. Finally, micro-engineering was used
to build a magnetoresistive Magnetic Tweezer device for detection of single molecule DNA modify-
ing enzymes (motors), while the possibility of constructing a Hall Effect version of this device was
explored. The device is currently being used to study helicases from Plasmodium as potential targets
for anti-malarial drugs, but we also suggest other potential uses for the device.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction another view of this deﬁnition of Synthetic Biology is the use of bio-One deﬁnition of Synthetic Biology is ‘‘the application of engineer-
ing principles to the study of the fundamental components of biology’’,
but there are major problems associated with this basic premise –
biological systems are very different from electronic systems, or
chemical systems, and new combinations do not always behave as
expected. One example of this engineering styled approach, applied
to protein production, is the use of ‘‘bioparts’’1 from a database
and the construction of novel combinations of these ‘‘bioparts’’ to pro-
duce the required proteins. The ‘‘bioparts’’ consist of speciﬁc gene se-
quences, promoters, terminators, tag systems for afﬁnity puriﬁcation
and cleavage sites that allow release of the required protein. Each of
these ‘‘bioparts’’ can be joined using a simple, identical system in a
cassette-like manner allowing a potentially large number of different
combinations. Such a system is often commercially available as a kit-
based expression system (e.g. ATG: biosynthetics2). However, when
this concept is applied to the assembly of novel components of a gene
expression system, the production of novel proteins from any speciﬁc
combination of gene and promoter is not guaranteed [1]. Problems
usually arise from the unexpected loss of protein solubility. However,cal Societies. Published by Elsevier
irman), jim.youell@port.ac.uk
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e=acembl-mix-and-matchlogical components in the construction of useful devices, such as bio-
sensors, using modular approaches associated with engineering
principles. When such techniques are combined with the concepts of
nanotechnology (single molecule manipulation and construction on a
sub-100 nm scale), truly exciting and useful devices can be imagined.
We ﬁrst outlined the construction of such a device following our
studies with the Type I Restriction-Modiﬁcation enzyme EcoR124I
[2,3] using a Magnetic Tweezer system [4,5] to measure the pulling
force (in pN) on DNA by the DNA-bound enzyme via motion of a
paramagnetic bead attached to one end of the tethered DNA
substrate. The original concept for a new device was an electronic
version of this Magnetic Tweezer setup, which would be attached
to amicroﬂuidics system and allow real time detection ofmolecular
motor activity in a highly parallel, semi-automatic system (Fig. 1).
This system could then be used to study a variety of DNAmodifying
enzymes, many of which are potential targets for drug development
(e.g. helicases, topoisomerases and recombinases).
In addition, the project required two other components to be
developed, which were seen as a key aspect of developing a
Synthetic Biology Project:
1. Construction of cassette-based gene expression systems that
would allow over-production of the required proteins and easy
puriﬁcation of these proteins for use in the device. This could
act as one part of a documented ‘‘biopart’’ system, which would
be an example for other systems.B.V. Open access under CC BY-NC-ND license.
Fig. 1. An electronic Magnetic Tweezer setup in a microﬂuidics channel. In this initial version of the proposed device Hall Effect sensors [48] were proposed as electronic
detectors of vertical bead movement. DNA strands are attached as single molecules above single Hall Effect sensors placed within a microﬂuidics channel. The DNA with
digoxigenin incorporated at one end is surface attached through a dithiobis(succinimidyl propionate)(DSP) to link anti-digoxigenin antibodies on a 100 nm2 gold patch, which
was located above the sensor, while the paramagnetic bead is attached to the DNA though a biotin-streptavidin linkage. An external magnetic ﬁeld (not shown) holds the
attached paramagnetic beads in a vertical position slightly stretching the DNA. The EcoR124I molecular motors (shown in green) are introduced in two stages – the darker
green DNA-binding MTase followed by the light green motor component, which attaches to DNA adjacent to the enzyme [49] and translocates the DNA through the bound
complex producing supercoiled DNA [50]. This translocation results in vertical movement of the DNA-bound bead, which generates an electrical signal in the Hall Effect
sensor (represented by the red colouring) and this output, from a single motor, can be measured in the device and displayed as shown. Random release of the DNA results in
resetting of the vertical position of the paramagnetic bead.
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nents to allow surface attachment, bead attachment of the DNA
and a central, motor-speciﬁc binding site that would ensure
directed assembly of the motor at the required site. This can
be seen as a variant of the ‘‘biopart’’ system where DNA alone
is the ‘‘biopart’’. This is a key aspect of analysing DNA modifying
enzymes where different enzymes will need different sub-
strates within the device, but a common method of attachment
to surface and bead.
Finally, although initial development was to be based around
the EcoR124I molecular motor, a novel system was required to
identify problems associated with actual use of the proposed de-
vice and to enable development of a potential commercial applica-
tion. As mentioned above, some types of DNA manipulating
enzymes are ATP motors and are consequently useful models for
study. DNA helicases were already the subject of studies using
Magnetic Tweezer systems [6,7] and seemed a useful source of
material. However, we also became particularly interested in one
source of novel helicases – Plasmodium falciparum – as it was pro-
posed that these enzymes might be used as targets for anti-malar-
ial drug discovery [8]. This would also ensure that substrate
development would be a key aspect of the project – designing a
variety of special substrates to identify the type of helicase being
studied. A great number of studies have been conducted on thebulk assay of helicase activity and it was imperative that a range
of substrates reﬂecting the diverse topologies of DNA in vivo were
analysed. As well as novel substrates, a range of substrates includ-
ing synthetic junctions, ﬂaps, bubbles and forks were designed
(Fig. 2) as previously described [9,10] to determine the topological
preference, polarity, processivity and nucleic acid preference of the
helicase motors studied.
Therefore, a clear Synthetic Biology Project was deﬁned and in-
cluded the following stages:
1. Production of a cassette gene expression system for reliable iso-
lation of molecular motor proteins.
This would also allow us to determine reliability of the ‘‘engi-
neering’’ approach to gene expression and to detail problems
associated with any speciﬁc protein production (we believe
such information must be an important part of any ‘‘bioparts’’
database).
2. Production of a variety of substrate DNA molecules and assem-
bly of these into a Magnetic Tweezer system.
Allowing us to better understand how the Plasmodium heli-
cases function and which substrates might be the most appro-
priate for use in the proposed project.
3. Development of an electronic Magnetic Tweezer setup, includ-
ing an external magnetic ﬁeld for lifting the paramagnetic beads
and a microﬂuidic system for delivery of motor proteins to the
Fig. 2. DNA substrates for analysis of helicase activity. A range of substrates based
on those previously described [9,10] were annealed. Visualisation of substrates and
unwound products was enabled by the addition of a ﬂuorescein (denoted by ⁄) at
the 50 end of one of the constituent DNA strands.
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This would allow us to gain an understanding of problems asso-
ciated with substrate attachment above the sensors and the
sensitivity of such a device.
4. Investigation of the effect of simple drugs on the function of the
Plasmodium helicases.
This would provide the proof of principle for the use of the
device in a genuinely commercial situation.
The advantages of using a single molecule sensor for the analy-
sis of drug-target interactions has been clearly demonstrated for
Topoisomerase I [11], but another aspect of this project is thatdeveloping a nanotechnology-based device could open up the pos-
sibility of studying drug–target interactions at the very limit of
sensitivity – at or just below the Kd for the interaction.2. Results and Discussion
The ﬁrst stage for developing the proposed devicewas to demon-
strate single molecule activity of a DNA-manipulating molecular
motor within a conventional, optical Magnetic Tweezer system so
that this knowledge could be used in the design and study of the
combined optical/electronic Magnetic Tweezer device that was to
be developed during this project. The Type I Restriction-Modiﬁca-
tion enzyme EcoR124I and the DNA translocating enzyme FtsKwere
the motors used and both enzymes were extensively studied and
characterised [2,3,12,13]. The motor subunit of the EcoR124I en-
zyme was over-produced using a cassette-based system, which in-
cluded an N-terminal Glutathione S-Transferase (GST) tag linked
to the hsdR gene through a cleavable PrescissionTM Protease site
[14] and a pET vector based expression system. However, using a
His-tag with this protein, at the N-terminus, was found to produce
a product with low solubility – an interesting example of the oddi-
ties associatedwith protein production. The former resulted in large
amounts of soluble protein, which was easy to purify using the GST
tag and allowed assembly of the intact enzyme by mixing with the
core DNAMethyltransferase [15]. This work allowed us to develop a
simple initial device (without a ﬂowcell) that combined optical and
electronic measurement of the magnetic bead (see later).
Theﬁrst step toward productionof a helicase protein for usewith
the proposed device was to produce signiﬁcant levels of the PfeIF4A
protein from P. falciparum. This homologue to the archetypical hu-
man DEAD-box helicase, human eukaryotic initiation factor 4A iso-
form1 (eIF4A1), is essential for translation initiation and acts as part
of a larger initiation factor complex [17]. Comparison of the primary
amino acid sequence of PfeIF4A against the human eIF4A (eIF4A1,
NCBI accession number NP_001407) showed that the two se-
quences have identity of 67%, with almost complete conservation
of the core helicase superfamily 2 (SF2) motifs. However, the two
proteins exhibit signiﬁcantly different biochemical characteristics
and it was hoped that these differences could be exploited in order
to develop anti-malarial drugs against this novel target [8,18–20].
2.1. Production and characterisation of helicases from Plasmodium
Analysis of putative helicase genes derived from the genome
sequence of P. falciparum, identiﬁed a total of 45 full-length
open-reading frames (ORFs) encoding potential helicases [18,19].
However, helicase proteins isolated in these studies [21–26] were
only obtained in low concentrations, which made characterisation
difﬁcult. Therefore, we used a simple afﬁnity tag-based expression
system for protein production and to ensure high-level production
of the proteins in Escherichia coli we optimised the codon usage.
The full-length open reading frame (NCBI accession number
XM_001348793) from P. falciparum was synthesised and cloned
into pET28a and pGEX6P-1 (a service provided by GeneArt, Life
Technologies Corporation), to yield the recombinants, pJY-GST-
PfeIF4A and pJY-His-PfeI4A respectively. Both plasmid constructs
were conﬁrmed by restriction fragment mapping and DNA
sequencing. Following the model cassette-based system developed
for HsdR production, the pJY-GST-PfeIF4A construct was designed
to express a fusion protein with a Prescission™ Protease cleavable
N-terminal GST tag, whereas the pJY-His-PfeIF4A construct
encoded a fusion protein with a thrombin cleavable N-terminal
His-tag and a T7 tag [27,28].
Both clones were transformed into E. coli BL21(DE3) [pLysS] for
expression of the recombinant gene. A variety of expression tests
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of large amounts of protein of the correct molecular weight as
insoluble inclusion bodies, and despite various refolding proce-
dures it was not possible to obtain active protein using this con-
struct (another example of the problems of a simple engineering
approach to protein production). Work continued on the pJY-His-
PfeI4A construct and this yielded smaller amounts of soluble
protein after the growth conditions were optimised for maximal
production. Therefore, this project has already demonstrated two
unexpected situations where a simple ‘‘bioparts’’ approach to pro-
tein production was unsuccessful in an unpredictable way.
Pure PfeIF4A was obtained using an extended puriﬁcation to
that described previously [22] in order to remove a contaminating
native E. coli helicase (as conﬁrmed by mass spectrometry). In
short, a Ni–NTA agarose column (Qiagen) was used to isolate the
His-tagged protein. Then this sample was applied to a HiTrap Hep-
arin HP column (GE Healthcare) and subsequently to a HiLoad 26/
60 Superdex S200 Prep Grad column (GE Healthcare). Pure samples
of PfeIF4A (as determined by SDS–PAGE) were obtained at a ﬁnal
concentration 50 lM and stored as aliquots at -20C. The aforemen-
tioned presence of an E. coli contaminating helicase was another
unexpected observation, which shows that biological systems are
not easy to deal with in a simple ‘‘engineering-inspired’’ way!
The contaminating protein appeared to bind the PfeIF4A protein
through non-covalent association and was co-puriﬁed following
afﬁnity chromatography.
Following isolation of puriﬁed PfeIF4A protein it was necessary
to identify which substrate DNA would be the most appropriate for
use in a Magnetic Tweezer system. As mentioned previously, a ser-
ies of ﬂuorescently labelled substrates were adapted from those
previously published [9,10] in order to determine the biochemical
parameters of the PfeIF4A (Fig. 2). These included branched, nicked
and hairpin substrates amongst others. The synthesised ﬂuores-
cein-tagged substrates allowed the characterisation of the helicase
activity using the well documented strand displacement assay that
allows the displacement of the annealed strands to be monitored
by following the relative gel shift by native gel electrophoresis.
Results from substrate unwinding assays conﬁrmed that PfeI-
F4A was a slowly processive helicase requiring a substrate with a
single stranded region, in order to bind and subsequently unwind
substrates, and that the enzyme had signiﬁcant bipolar activity
(unwinding was observed in both 50-30 and 30-50 directions).
Subsequently a Forked substrate (Fork 1 – Fig. 2) was determined
as the best substrate to continue with for future Magnetic Tweezer
experiments. For Magnetic Tweezer work, the use of various sub-
strates would allow us to determine potential activity on a range
of in vivo mimics.
However, initials studies of this system using a conventional
Magnetic Tweezer system conﬁrmed problems associated with
the kinetics of this slow helicase (unpublished observations). Based
on the above ﬂuorescent gel based assay, the PfeIF4A helicase exhib-
its a slow rate of unwinding/translocation, which prevents reliable
assays within a Magnetic Tweezer setup. Therefore, at the time of
publication of this article, work continues to determine if it will
be possible to use single molecule measurement of helicase activity
with other Plasmodium-derived proteins,which have been isolated.
2.2. Developing an electronic version of a Magnetic Tweezer setup
It was clear at the outset of this project that two sensing sys-
tems were possible for use within the proposed electronic Mag-
netic Tweezer device:
1. A Hall Effect sensor that might be assembled into a microﬂui-
dics channel [29].
The Hall Effect is the production of a voltage difference (the Hallvoltage) across an electrical conductor, transverse to an electric
current in the conductor and a magnetic ﬁeld perpendicular to
the current [30], which has been widely used in biosensing sys-
tems involving detection of changing magnetic ﬁelds [31,32].
This approach was an interesting exploration of a novel tech-
nique for assembling the Hall Effect sensors using an electron
beam to generate the conductors [33], whichwould be an impor-
tant contribution to basic science and, hopefully, to the project.
2. A Magnetoresistive sensor [34], which could be readily con-
structed within a microﬂuidics environment.
The magnetoresistive effect is a quantummechanical effect, due
to electron spin, in which a signiﬁcant reduction of electrical
resistance is produced in a thin-layer structure of alternating
magnetic and non-magnetic layers in the presence of an exter-
nal magnetic ﬁeld [35]. Our collaborators had developed this
technology for detection of DNA on a chip [36], which was a
useful place to start this project.
The hope with this approach was for the rapid development of a
chip-based device as there was a signiﬁcant amount of knowl-
edge regarding the use of these devices with biological systems
[34,36–39].
Much of the initial work with the Hall Effect sensors revolved
around reliability and sensitivity measurements as the construc-
tion technique was novel and this work included preparation of
nano-sized paramagnetic particles for detection at the limits of
sensitivity using the prepared Hall Effect sensors and more con-
ventional versions of Hall Effect sensors. This work is on going
and it has become clear that the concept is possible, but we have
yet to realise construction of a useful device.
Progress with the magnetoresistive device was both rapid and
successful. The ﬁrst stage developmentwas based on ahanging drop
system (Fig. 3A) where magnetic beads and biomolecules were
introduced in a 20 ll drop of buffered solution. However, a major
problem encountered with this system was attachment of the bio-
molecules above the sensor. Initial attempts to attach DNA to the
surface above the sensor were based on a chemical attachment
using a thiol group incorporated onto the DNA substrate and a
gold-coated surface, located above the magnetoresistive sensor.
However, this technology gave poor efﬁciency of binding and re-
sulted in non-speciﬁc interactions within the system, as well as
making regeneration of the chips difﬁcult. Improved surface attach-
ment techniques were developed using dithiobis(succinimidyl pro-
pionate)(DSP) to link anti-digoxigenin antibodies to a 100nm2 gold
patch, which was located above the sensor.
The DNA substrates were, therefore, designed from three DNA
products (Fig. 4) with relevant restriction sites to allow easy
directional ligation: a short PCR product incorporating digoxi-
genin-11-UTP (for binding to the antibody functionalised gold sur-
face), the DNA substrate of interest, and another short PCR
product incorporating biotin-16-dUTP (for binding to a streptavidin
functionalised paramagnetic bead). The inclusion of multiple mod-
iﬁed nucleotides at either end of the substrate were hoped to crowd
the relevant surface to be attached and push the ratios of binding to
1:1 in each case, which was conﬁrmed using Scanning Electron
Microscopy (SEM) based analysis of functionalised/DNA bound/
washed surfaces. In addition, this initial device incorporated a glass
base, which allowed observation of the bead in a standard optical
Magnetic Tweezer system and consequently dual measurement of
bead movement by optical and electronic means. Development of
the initial drop-based MRMT device was described by Chaves et
al. [40].
Following this initial development of a single drop device,
which was used to conﬁrm detection of, movement of the
paramagnetic bead and attachments of the DNA substrates for
use with the EcoR124I motor, a device was proposed, incorporating
Fig. 3. A prototype MagnetoResistive Magnetic Tweezer (MRMT) system. (A) On the left is a cartoon representation of the ﬁrst prototype MRMT device, which is illustrated as
a breadboard device on the right side of the ﬁgure. The required external magnetic ﬁeld, required to hold up the paramagnetic bead and stretch the attached DNA, is provided
by a small coil (in blue) powered by IDC while the magnetoresistive sensor is illustrated in grey [40]. (B) A simple microﬂuidics ﬂowcell was produced with multiple sensors as
in (A) and connected to external input using a simple connector [40].
}
}
}
} EcoRI restriction site
PCR Product incorporating biotin-16-dUTP 
} EcoRI restriction site
} BamHI restriction site
Annealed Branched Substrate
} BamHI restriction site
PCR Product incorporating digoxigenin-11-UTP  
Fig. 4. Method of attachment of DNA substrates in a Magnetic Tweezer setup. Example of a composite fork-like substrate attached to a paramagnetic bead and a
functionalised gold surface. Binding of the substrate to the bead is mediated through the interaction of multiple biotin molecules and the streptavidin functionalised surface
of the bead. Binding to the surface is via a speciﬁc interaction with anti-DIG antibodies, which in turn interact with the surface via the DSP cross-linker. The substrate DNA,
highlighted by the blue bracket – } – can be any of the substrates illustrated in Fig. 2.
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Tweezer (MRMT) device, to deliver biomaterials to the sensor. Fi-
nally, the DC operated coil used to hold up the paramagnetic bead
also enables vertical manipulation of the bead during surface
attachment of the DNA, which overcomes non-speciﬁc attachment
of the bead within the chamber. Following this initial work the
proposed simple ﬂowcell version of the device was constructed
with multiple MT areas within the ﬂow-chamber and attached to
a feeder inlet of 100 ll volume (Fig. 3B).While the real potential of this MRMT device has yet to be dem-
onstrated, some of the capabilities include:
1. The use of pulsed electrical current in the coil to wind DNA so as
to create supercoils in the DNA for use with some substrates
(e.g. topoisomerases).
2. The potential to measure with smaller beads that cannot be
observed using an optical system, which would reduce the
effect of the bead on motor activity.
2162 K. Firman et al. / FEBS Letters 586 (2012) 2157–21633. The possibility of parallel channels that allow direct comparison
of the same motor/substrate combinations in the presence of
different temperature, ﬂow rates and in the presence or absence
of drugs and other chemicals.
4. Development of a simple on/off measurement of a drug affect-
ing motor activity for rapid screening of drugs against targets.
5. The potential for measurement of drug–target interactions at
very low drug concentrations.
6. Development for use with novel DNA substrates (e.g. quadru-
plex DNA [41]) and the folding of aptamers for biosensing
[42,43].
7. Development of a system for the study of protein–protein inter-
actions, based around the model twin-hybrid system, where the
DNA substrate in the Magnetic Tweezer is looped by the inter-
action between two proteins fused to two different DNA-bind-
ing proteins.
2.3. Design of single molecule experiments to detect Plasmodium
helicase activity
Design of substrates for either the optical (conventional) Mag-
netic Tweezer or the electronic MMT device required the use of
modiﬁed versions of the bulk assay substrates in order to allow
the correct alignment of substrates with the surface. For either de-
vice the choice of microﬂuidic surface attachment was through
the speciﬁc interaction of digoxigenin(DIG)-11-UTP with anti-DIG
antibodies bound to the surface. Binding with the paramagnetic
bead was reliant on the well documented streptavidin–biotin inter-
action and therefore therewas a need to incorporate a region of bio-
tin-16-dUTP in a region of the DNA substrate. Substratesweremade
by ligating components (using a similar method to that described
earlier for the EcoR124I substrates [2] an example ofwhich is shown
in Fig. 4) and annealing of complimentary strands to produce the de-
sired substrate to mimic those described previously.
With a range of substrates developed as described it is easy to
see how a high throughput translocase/helicase characterisation
and drug screening system could be produced. With a correctly
implemented multi channel microﬂuidic system with multiple
sensing devices in each, the analysis of enzyme activity and also
drug inhibition, on different substrates, could be monitored in par-
allel with repeats on the same chip. Alternatively, simply by using
the same substrate throughout the system, libraries of inhibitors
could be screened for speciﬁc hits against one target enzyme
quickly and effectively.3. Conclusions
In this paperwedescribe an ambitious Synthetic Biology andBio-
nanotechnology Project, which has involved three consecutive re-
search grants funded by European sources. The concept was to
construct an electronic device for single-molecule measurement of
drug–target interactions at the very limit of sensitivity. The project
is still ongoing at the time ofwriting this review, but signiﬁcant pro-
gress has beenmade from the ﬁrst steps, which involved answering
the question ‘‘canwe detect movement of a magnetic bead attached to
DNA, using a singlemoleculemolecularmotor tomanipulate the DNA’’?
We have documented the capability of an optical Magnetic
Tweezer system for measurement of movement by two DNA trans-
locators (EcoR124I [2] and FtsK [12]) and fully characterised DNA
translocation by these molecular motors. This work was then ex-
panded to characterise other motors, including DNA helicases [7],
which led to the concept of expanding this study to the characterisa-
tion of novel helicases from Plasmodium falciparum, which are po-
tential drug targets for development of new anti-malarial drugs
[8]. At this time work continues to identify a suitable helicase formeasurement with the MRMT device developed during the project,
but the device hasmany other potential uses that can be developed.
A Synthetic Biology approach for isolation of new recombinant
clones of the Plasmodium helicase genes was adopted and proteins
puriﬁed from E. coli strains that guaranteed high-level production
of the proteins. The helicases have been characterised using stan-
dard techniques and single molecule characterisation has just
started at the time of preparation of this paper. However, we have
also documented problems associated with this engineering-based
approach of using a cassette system to link ‘‘bioparts’’ as well as
interesting (unexpected) problems associated with protein puriﬁ-
cation. Therefore, the Project has provided strong evidence that
any database of bioparts must include such negative observations
to enable productive use of the bioparts.
Finally, we have successfully constructed an electronic version
of a Magnetic Tweezer system, demonstrated assembly of DNA
substrates within the device and motor activity [40]. This device
is an important example of incorporating a biological system into
a micro-engineered construct. Therefore, the project has been very
successful and the possibilities now exists of developing a com-
mercial device that can detect drug–target interactions at the sin-
gle molecule level, where sensitivity should be based on the kd for
the interaction, and characterise the nature of these interactions.
The future for this project could be wide ranging, with the pos-
sibility of using the device for the study of systems that involve
changes to DNA topology – aptamers [44], where the device could
be used as a biosensor for detection of the aptamer target mole-
cule; quadruplex DNA [45], where DNA-binding drugs that inhibit
quadruplex formation might be identiﬁed and used for speciﬁc dis-
ease treatments [46]; the study of protein-protein interactions by
adapting the system to mimic the DNA looping concept of the
two-hybrid system [47], etc.
This project has shown that applying engineering techniques to
biological systems can work very well and that incorporation of
nanotechnology and miniaturisation will produce novel devices
with a wide ranging capability for the future.Acknowledgements
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